• Home

  • About

  • All News

  • Press Releases

  • Network

  • More

    Use tab to navigate through the menu items.
    • LinkedIn

    District 


    Driven by

    Intelligence™
    biotech brothers

    • All Posts
    • News
    • Pharma
    • Opinion
    • Money
    • Intelligence
    • Marketing
    Search
    FDA Greenlights Jazz Pharmaceutical's Xywav for Idiopathic Hypersomnia
    Staff
    • Aug 20, 2021
    • 2 min

    FDA Greenlights Jazz Pharmaceutical's Xywav for Idiopathic Hypersomnia

    FDA approves first of its kind indication for chronic sleep disorder treatment The U.S. Food and Drug Administration on August 12 grants...
    FDA Greenlights First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes
    Staff
    • Aug 2, 2021
    • 3 min

    FDA Greenlights First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes

    The U.S. Food and Drug Administration on July 28 announced the approval of the first interchangeable biosimilar insulin product aimed at...
    FDA Questions Safety of Roxadustat Ahead of AdComm Review
    Staff
    • Jul 23, 2021
    • 3 min

    FDA Questions Safety of Roxadustat Ahead of AdComm Review

    FibroGen and AstraZeneca have been pushing for a better heart safety profile for their likely top-of-the-shelf anemia med roxadustat...
    Novo’s Semaglutide Won its Coveted FDA Green Light to Treat Obesity
    Staff
    • Jun 13, 2021
    • 2 min

    Novo’s Semaglutide Won its Coveted FDA Green Light to Treat Obesity

    With obesity prevalent, undertreated, and hugely misunderstood, Novo Nordisk has been attempting to revolutionize the field with...
    AstraZeneca Moves Closer to Acquiring Alexion For $39 Billion
    Staff
    • May 2, 2021
    • 2 min

    AstraZeneca Moves Closer to Acquiring Alexion For $39 Billion

    Just as pharma observers were bracing themselves for the brunt of renewed antitrust scrutiny around monumental Biopharma transactions,...
    Sanofi Breaks Up with Oxford Biomedica's Hemophilia Drug
    Staff
    • Apr 3, 2021
    • 2 min

    Sanofi Breaks Up with Oxford Biomedica's Hemophilia Drug

    In only a few weeks after Sanofi agreed to purchase Bioverativ to establish a foothold in hemophilia, the smaller company scored a...
    Lilly uses Infusion Centers to Increase Access to Covid Antibodies
    Staff
    • Feb 5, 2021
    • 2 min

    Lilly uses Infusion Centers to Increase Access to Covid Antibodies

    Eli Lilly’s Covid-19 monoclonal antibody isn’t getting as much use as it could as a result of logistical issues. So the drugmaker is...
    Merck Looks For FDA Review for 15-strain Pneumonia Vaccine
    Staff
    • Jan 14, 2021
    • 2 min

    Merck Looks For FDA Review for 15-strain Pneumonia Vaccine

    Prevnar 13, Pfizer’s $5.8 billion-a-year vaccine is unarguably one of the firm’s top blockbusters and the undisputed leader in the...
    Astellas' Chronic Kidney Disease Drug (EVRENZO) Breaks into the Japanese Market 🇯🇵
    Staff
    • Dec 10, 2020
    • 2 min

    Astellas' Chronic Kidney Disease Drug (EVRENZO) Breaks into the Japanese Market 🇯🇵

    FibroGen, Inc. and Astellas Pharma Inc. announced on Friday that Japan’s Ministry of Health, Labor and Welfare (MHLW) approved EVRENZO...
    After EUA Win for Bamlanivimab, Lilly Heads to Canada 🇨🇦
    Staff
    • Nov 23, 2020
    • 2 min

    After EUA Win for Bamlanivimab, Lilly Heads to Canada 🇨🇦

    Eli Lilly and Company announced on Friday that Canada had granted authorization for the use of bamlanivimab (LY-CoV-555) as a treatment...
    Pfizer Vaccine is 90% Effective in Preventing COVID19
    Staff
    • Nov 10, 2020
    • 2 min

    Pfizer Vaccine is 90% Effective in Preventing COVID19

    Pfizer and its partner BioNTech announced a major breakthrough earlier on Monday after a preliminary analysis found the vaccine to be...
    Alkermes Reigns in with New Schizophrenia Drug 🧠💸
    Staff
    • Oct 15, 2020
    • 2 min

    Alkermes Reigns in with New Schizophrenia Drug 🧠💸

    Alkermes plc. announced positive voting outcomes from the joint meeting of the Drug Safety and Risk Management and the...
    Amgen's KRAS Inhibitor Reduces Non-Small Cell Lung Cancer in a Phase I Clinical Trial
    Staff
    • Sep 23, 2020
    • 2 min

    Amgen's KRAS Inhibitor Reduces Non-Small Cell Lung Cancer in a Phase I Clinical Trial

    Amgen is pulling the curtain on full data after releasing small snippets about its keenly watched KRAS inhibitor. The drug, tagged...
    Chi Med Submits New Drug Application for Surufatinib to Treat Pancreatic Cancer
    Staff
    • Sep 20, 2020
    • 1 min

    Chi Med Submits New Drug Application for Surufatinib to Treat Pancreatic Cancer

    Chinese biotech company Hutchison China MediTech, popularly known as Chi-Med, on Thursday announced that its Second NDA for Surufatinib...
    Marinus Pharmaceuticals Meets Phase 3 Endpoints for Epilepsy
    Staff
    • Sep 17, 2020
    • 2 min

    Marinus Pharmaceuticals Meets Phase 3 Endpoints for Epilepsy

    Marinus Pharmaceuticals, Inc., a pharmaceutical firm dedicated to developing innovative therapeutics to treat rare seizure disorders,...
    I-Mab Partners with AbbVie to Develop and Commercialize an anti-CD47 mAb
    Staff
    • Sep 10, 2020
    • 2 min

    I-Mab Partners with AbbVie to Develop and Commercialize an anti-CD47 mAb

    Chinese biotech, I-Mab, has signed a deal with AbbVie for the development and commercialization of I-Mab’s highly differentiated...
    Does Dexamethasone Benefit Patients Fighting Covid19?
    Staff
    • Sep 8, 2020
    • 2 min

    Does Dexamethasone Benefit Patients Fighting Covid19?

    According to three newly published clinical trials, affordable, widely available steroid drugs lowered the number of deaths in the...
    Nestle Acquires Aimmune for $2.6 Billion 💸
    Staff
    • Sep 2, 2020
    • 2 min

    Nestle Acquires Aimmune for $2.6 Billion 💸

    Aimmune (AIMT) a biopharmaceutical startup agreed to be acquired by Nestle for $2.6 Billion or $34.50 dollars a share. Before the...
    Justice Department Sues Teva for Pharmaceutical Kickback Scheme
    Staff
    • Aug 21, 2020
    • 2 min

    Justice Department Sues Teva for Pharmaceutical Kickback Scheme

    The US Department of Justice has lodged a False Claims Act complaint against Teva Pharmaceuticals USA Inc. The department claimed that...
    Will Kodak Cash into Pharma?  A $765 Million Deal Might Do it
    Staff
    • Aug 16, 2020
    • 2 min

    Will Kodak Cash into Pharma? A $765 Million Deal Might Do it

    Kodak’s latest bungling of its exceptional $765 million deal with the federal government to start production of pharmaceuticals – a deal...
    1
    2

    Back to Top

    Subscribe to Our Newsletter

    Thanks for submitting!

    • Home
    • About
    • All News
    • Press Releases
    • Network

    Support Journalism
     

    • White Facebook Icon

    © 2020 by BiotechDistrict Subsidiary of Biotech Brothers LLC. Proudly Independent.